细胞凋亡
基因沉默
癌症研究
程序性细胞死亡
抑制器
癌症
癌细胞
细胞
坏死
生物
肿瘤坏死因子α
内生
受体
抑癌基因
配体(生物化学)
HEK 293细胞
免疫学
细胞生物学
细胞培养
基因剔除小鼠
医学
上皮
化学
细胞毒性
作者
John Canty,Scot A. Marsters,David Lawrence,Serena Lee,Hartmut Koeppen,Avi Ashkenazi
标识
DOI:10.1038/s41418-026-01798-3
摘要
Cancer cells avert apoptosis to sustain growth, evade immunity, and resist therapy. However, how they escape specific extrinsic death signals remains unclear. We show that certain epithelial carcinomas co-opt the death-receptor ligand Apo2L/TRAIL to suppress apoptosis while acquiring killing capacity. Analysis of CRISPR knockout screens from the Cancer Dependency Map uniquely identified TRAIL as an essential tumor necrosis factor superfamily member in epithelial malignancies. Renal cell carcinomas (RCC) and squamous cell carcinomas (SCC) expressed TRAIL within both malignant and nonmalignant compartments. In RCC, loss of the tumor suppressor VHL induced HIF2α-dependent TRAIL transcription, whereas in SCC, 3q26 amplification increased TRAIL abundance. Fractional TRAIL silencing revealed killing of TRAIL-deficient cells by TRAIL-expressing counterparts, while full silencing sensitized cells to extrinsic TRAIL. Mechanistically, endogenous TRAIL suppressed apoptosis through lysosomal degradation of its cognate death receptors. Thus, cancer cells can repurpose TRAIL via a surprising apoptotic "cloak-and-dagger" mechanism with significant therapeutic potential.
科研通智能强力驱动
Strongly Powered by AbleSci AI